A number of lines of inquiry have suggested a potential association between multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). For example, familial aggregation studies have found increased risk for MS in adult children when a parent is diagnosed with ALS [1, 2] . Case reports indicate co-occurrence of MS and ALS in patients [3] . The two disorders share some pathogenic features, such as inflammation, oxidative stress, and mitochondrial dysfunction, suggesting a possible common biological pathway [4, 5] . Finally, a neuroepidemiologic study of the distribution of MS and ALS in Sweden between 1952 and 1992 seemed to confirm the association. Across the 24 Swedish counties, average annual mortality attributed to ALS and MS in death records was significantly correlated (rho = 0.49, p = 0.015) [6] .
In this issue of Neuroepidemiology , the authors have returned to mortality in MS and ALS across Swedish counties to examine the relationship in more recent decades, 1990-2010 [7] . Surprisingly, they found no association between mean annual age-and sex-adjusted mortality for the two diseases (rho = -0.05, p = 0.82). Repeating analyses for the different decades to account for the introduction of new immunomodulating treatments for MS did not change results. The authors conclude that their study 'failed to confirm the previously shown association between the mortality from MS and ALS, respectively, in Sweden'.
Why such different findings, and what lessons should we draw from this inability to replicate prior results? It should be said right away that the authors deserve praise for seeking to replicate the prior results, which, as they admit, were unexpected and not the object of their original study. They deserve praise as well for pointing out this failure to replicate. Their candor in admitting that they cannot fully explain differences between findings from 1952-1992 and 1990-2010 is also welcome. This humility is part of good science.
Yet the authors also do not want to abandon the hypothesis: 'given the indirect measure of the disease used in the present
